Schedule 13G ownership disclosure

ZHENGYE BIOTECHNOLOGY HLDG L

Ordinary shares, par value $0.000025 per share · CUSIP: G989MS101

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Securingium Holding Limited

    Shares: 42,963,748.00 · Class: 90.66%

  • TSet Holding Limited

    Shares: 42,963,748.00 · Class: 90.66%

  • Trident Trust Company (HK) Limited

    Shares: 42,963,748.00 · Class: 90.66%

  • Jiahe Developments Limited

    Shares: 42,963,748.00 · Class: 90.66%

  • Vanguards Skyline Holdings Limited

    Shares: 42,963,748.00 · Class: 90.66%

  • Changchun Feier Investment Center (Limited Partnership)

    Shares: 42,963,748.00 · Class: 90.66%

  • VVAX Holdings Limited

    Shares: 42,963,748.00 · Class: 90.66%

  • Jilin Zhengye Group Co., Ltd.

    Shares: 42,963,748.00 · Class: 90.66%

  • Zhenfa Han

    Shares: 42,963,748.00 · Class: 90.66%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-016099
Form type
SCHEDULE 13G
Filer
SECURINGIUM HOLDING Ltd
CIK
CIK 2057331
Filed
Feb 21, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub